These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23490285)

  • 1. DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes.
    Wang Z; Zheng Y; Hou C; Yang L; Li X; Lin J; Huang G; Lu Q; Wang CY; Zhou Z
    J Autoimmun; 2013 Mar; 41():50-9. PubMed ID: 23490285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression.
    Fragale A; Gabriele L; Stellacci E; Borghi P; Perrotti E; Ilari R; Lanciotti A; Remoli AL; Venditti M; Belardelli F; Battistini A
    J Immunol; 2008 Aug; 181(3):1673-82. PubMed ID: 18641303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro immunomodulatory activity of interferon alpha on toll-like receptor 9 signaling pathway in chronic hepatitis B.
    Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y
    J Interferon Cytokine Res; 2015 May; 35(5):385-91. PubMed ID: 25535670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.
    Schroder K; Lichtinger M; Irvine KM; Brion K; Trieu A; Ross IL; Ravasi T; Stacey KJ; Rehli M; Hume DA; Sweet MJ
    J Leukoc Biol; 2007 Jun; 81(6):1577-90. PubMed ID: 17360957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distal regulatory region is required for constitutive and IFN-beta-induced expression of murine TLR9 gene.
    Guo Z; Garg S; Hill KM; Jayashankar L; Mooney MR; Hoelscher M; Katz JM; Boss JM; Sambhara S
    J Immunol; 2005 Dec; 175(11):7407-18. PubMed ID: 16301648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
    Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
    J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.
    Wang YY; Wang Q; Sun XH; Liu RZ; Shu Y; Kanekura T; Huang JH; Li YP; Wang JC; Zhao M; Lu QJ; Xiao R
    Br J Dermatol; 2014 Jul; 171(1):39-47. PubMed ID: 24641670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
    Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults.
    Li Y; Zhao M; Hou C; Liang G; Yang L; Tan Y; Wang Z; Yin H; Zhou Z; Lu Q
    Diabetes Res Clin Pract; 2011 Nov; 94(2):242-8. PubMed ID: 21864931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CTLA-4 expression in CD4+ helper T-cells in patients with fulminant type 1 diabetes.
    Haseda F; Imagawa A; Murase-Mishiba Y; Sano H; Hirano-Kuwata S; Ueda H; Terasaki J; Hanafusa T
    Immunol Lett; 2011 Sep; 139(1-2):80-6. PubMed ID: 21620894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
    Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
    Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
    Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
    Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc supplementation induces CD4
    Maywald M; Rink L
    Eur J Nutr; 2017 Aug; 56(5):1859-1869. PubMed ID: 27260002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Engagement of TLR9 Ligand with T Helper Cells Leads to Cell Proliferation & Up-regulation of Cytokines.
    Sharma RK; Sehgal S; Sachdeva N; Kumar R; Gupta A
    Immunol Invest; 2019 Jan; 48(1):79-95. PubMed ID: 30239236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.